Soleno Therapeutics Statistics

Total Valuation

SLNO has a market cap or net worth of $2.46 billion. The enterprise value is $2.18 billion.

Market Cap	2.46B
Enterprise Value	2.18B

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

SLNO has 43.12 million shares outstanding. The number of shares has increased by 271.22% in one year.

Current Share Class	38.87M
Shares Outstanding	43.12M
Shares Change (YoY)	+271.22%
Shares Change (QoQ)	+8.41%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	54.78%
Float	21.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.85
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 17.26, with a Debt / Equity ratio of 0.01.

Current Ratio	17.26
Quick Ratio	17.16
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -91.11% and return on invested capital (ROIC) is -59.39%.

Return on Equity (ROE)	-91.11%
Return on Assets (ROA)	-48.05%
Return on Capital (ROIC)	-59.39%
Revenue Per Employee	n/a
Profits Per Employee	-$3.97M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +146.80% in the last 52 weeks. The beta is -1.44, so SLNO's price volatility has been lower than the market average.

Beta (5Y)	-1.44
52-Week Price Change	+146.80%
50-Day Moving Average	52.07
200-Day Moving Average	46.61
Relative Strength Index (RSI)	62.78
Average Volume (20 Days)	518,487

Short Selling Information

The latest short interest is 5.71 million, so 13.25% of the outstanding shares have been sold short.

Short Interest	5.71M
Short Previous Month	4.96M
Short % of Shares Out	13.25%
Short % of Float	26.94%
Short Ratio (days to cover)	7.51

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-138.47M
Pretax Income	-65.41M
Net Income	-131.16M
EBITDA	-136.50M
EBIT	-138.47M
Earnings Per Share (EPS)	-$3.47

Full Income Statement

Balance Sheet

The company has $256.78 million in cash and $3.03 million in debt, giving a net cash position of $281.69 million or $6.53 per share.

Cash & Cash Equivalents	256.78M
Total Debt	3.03M
Net Cash	281.69M
Net Cash Per Share	$6.53
Equity (Book Value)	264.70M
Book Value Per Share	6.45
Working Capital	243.24M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.42 million and capital expenditures -$210,000, giving a free cash flow of -$51.63 million.

Operating Cash Flow	-51.42M
Capital Expenditures	-210,000
Free Cash Flow	-51.63M
FCF Per Share	-$1.20

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SLNO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-271.22%
Shareholder Yield	-271.22%
Earnings Yield	-5.32%
FCF Yield	-2.10%

Analyst Forecast

The average price target for SLNO is $69.86, which is 22.45% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$69.86
Price Target Difference	22.45%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 26, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 26, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2